[Pharmacologic therapy of atherosclerosis (I). Current possibilities].
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology; D002784:Cholesterol / Q000378:metabolism; D002994:Clofibrate / Q000627:therapeutic use*; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use; D015248:Gemfibrozil; D006025:Glycosaminoglycans / Q000627:therapeutic use; D006801:Humans; D007475:Ion Exchange Resins / Q000627:therapeutic use; D008074:Lipoproteins / Q000378:metabolism; D009539:Nicotinic Acids / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D006025:Glycosaminoglycans; D007475:Ion Exchange Resins; D008074:Lipoproteins; D009539:Nicotinic Acids; D010421:Pentanoic Acids; C009746:etofibrate; D002995:Clofibric Acid; D002784:Cholesterol; C006012:fenofibric acid; D002994:Clofibrate; D011341:Probucol; D015248:Gemfibrozil; D011345:Fenofibrate
Terapéutica farmacológica de la arteriosclerosis (I). Posibilidades actuales.